A study for a 53 year old man who takes Vascepa - from FDA reports
49 males aged 53 (±5) who take the same drug are studied. This is a personalized study for a 53 year old male patient who has Hypertriglyceridaemia. The study is created by eHealthMe based on reports from FDA.
How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.
Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).
49 males aged 53 (±5) who take Vascepa are studied.
Number of reports submitted per year:
Information of the patient in this study:
- Age: 53
- Gender: male
- Conditions: Hypertriglyceridaemia
- Drugs taken:
- Vascepa (icosapent ethyl)
eHealthMe real world results:
Comparison with this patient's adverse outcomes:
- Fatigue(feeling of tiredness): 0 (0% of males aged 53 (±5) who take the drug)
As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea
- Fatigue in Hypertriglyceridaemia (excess of triglycerides in the blood): 22 (6.98% of males aged 53 (±5) who have Hypertriglyceridaemia)
As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea
- Fatigue in Vascepa: 0 (0% of males aged 53 (±5) who take Vascepa)
Most common side effects over time
< 1 month:
- Headache (pain in head)
- Hypoaesthesia (reduced sense of touch or sensation)
- Heart rate increased
- Disturbance in attention
- Nausea (feeling of having an urge to vomit)
1 - 6 months:
- Sleep disorder
- Malaise (a feeling of general discomfort or uneasiness)
- Insomnia (sleeplessness)
- Anaemia (lack of blood)
- Low density lipoprotein increased (cholesterol increased in blood)
6 - 12 months:
- Pancreatic carcinoma (pancreatic cancer)
- Back pain
- Abdominal pain
- Metastases to liver (cancer spreads to liver)
1 - 2 years:
- Product odor abnormal
- Nausea (feeling of having an urge to vomit)
2 - 5 years:
- Cerebral haemorrhage (bleeding within the brain)
- Persecutory delusion
5 - 10 years:n/a
- Swelling face
- Heart disease
- Sinus headache (headache caused by sinus infections)
- Injection site reaction
- Cardiomyopathy alcoholic
Top conditions involved for these people *:
- Type Iia Hyperlipidaemia (abnormally elevated levels of any or all lipids and/or lipoproteins in the blood- type iia): 6 people, 12.24%
- Diabetes : 5 people, 10.20%
- Type 2 Diabetes : 4 people, 8.16%
- High Blood Pressure : 3 people, 6.12%
- Preventive Health Care : 3 people, 6.12%
Top co-used drugs for these people *:
- Zetia (7 people, 14.29%)
- Metformin (6 people, 12.24%)
- Juxtapid (5 people, 10.20%)
- Januvia (5 people, 10.20%)
- Androgel (5 people, 10.20%)
* Some reports may have incomplete information.
FDA reports used in this study
- Want to find out more about the FDA reports used in the study? You can request them from FDA.
You are not alone:
What are the drugs?
- Vascepa has active ingredients of icosapent ethyl. It is often used in high blood cholesterol. (latest outcomes from Vascepa 1,114 users)
What are the conditions?
- Hypertriglyceridaemia (excess of triglycerides in the blood) can be treated by Fenofibrate, Tricor, Lovaza, Gemfibrozil (latest reports from 8,699 Hypertriglyceridaemia patients)
What are the symtoms?
- Fatigue (feeling of tiredness) has been reported by people with multiple sclerosis, rheumatoid arthritis, high blood pressure, hepatitis c, depression (latest reports from 491,634 Fatigue patients).
Could your drugs cause:
Could your conditions cause:
- Vascepa side effects (1,101 reports)
Related publications that referenced our studies
- Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
- Will you have Acute Kidney Failure with Dexrazoxane?
- Will you have Hypotension with Slow-K?
- Will you have Renal Failure - Acute with Dexrazoxane?
- Will you have Blood Pressure Decreased with Slow-K?
- Will you have Kidney Failure with Dexrazoxane?
- Will you have Low Blood Pressure with Slow-K?
- Will you have Arf with Dexrazoxane?
- Will you have Renal Failure with Dexrazoxane?
- Afinitor and Herceptin drug interaction
- Evoxac and Plavix drug interaction
NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.